Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer

Phase 1

Completed

Conditions: Stomach Neoplasms

Interventions: Drug: capecitabine
Drug: oxaliplatin
Drug: cisplatin
Drug: sunitinib malate

First Posted Date: 2007-11-08

Last Posted Date: 2013-01-14

Lead Sponsor: Pfizer

Target Recruit Count: 76

Registration Number: NCT00555620

Locations: 🇰🇷
Pfizer Investigational Site, Seoul, Korea, Republic of

Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury

Phase 4

Terminated

Conditions: Brain Injuries
Growth Hormone Deficiency

Interventions: Drug: Genotropin
Drug: Placebo

First Posted Date: 2007-11-07

Last Posted Date: 2010-06-02

Lead Sponsor: Pfizer

Target Recruit Count: 10

Registration Number: NCT00555009

Locations: 🇬🇧
Pfizer Investigational Site, Salford, Manchester, United Kingdom

Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer

Phase 2

Completed

Conditions: Carcinoma, Non Small Cell Lung

Interventions: Drug: PF-00299804

First Posted Date: 2007-11-04

Last Posted Date: 2020-10-19

Lead Sponsor: Pfizer

Target Recruit Count: 55

Registration Number: NCT00553254

Locations: 🇰🇷
Seoul National University Hospital, Department of Internal Medicine, Seoul, Korea, Republic of
🇰🇷
Samsung Medical Center, Department of Medicine, Seoul, Korea, Republic of
🇰🇷
Severance Hospital, Yonsei University College of Medicine, Yonsei Cancer Center, Seoul, Korea, Republic of

Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer

Phase 1

Completed

Conditions: Stomach Neoplasms

Interventions: Drug: Cisplatin
Drug: S-1
Drug: Sunitinib

First Posted Date: 2007-11-04

Last Posted Date: 2015-03-13

Lead Sponsor: Pfizer

Target Recruit Count: 27

Registration Number: NCT00553696

Locations: 🇯🇵
Saku Central Hospital, GI Devision, Saku, Nagano, Japan
🇯🇵
Aichi cancer center central hospital / Medical Oncology, Nagoya, Aichi, Japan
🇯🇵
Shizuoka Cancer Center, Suntougun, Shizuoka, Japan

Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic

Phase 4

Completed

Conditions: Pain

Interventions: Drug: Ketoprofen 100mg
Drug: Parecoxib 40mg

First Posted Date: 2007-11-04

Last Posted Date: 2013-01-28

Lead Sponsor: Pfizer

Target Recruit Count: 340

Registration Number: NCT00553605

Locations: 🇵🇪
Pfizer Investigational Site, Lima, Peru

A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia

Phase 2

Completed

Conditions: Primary Insomnia

Interventions: Drug: PD 0200390
Other: Placebo

First Posted Date: 2007-10-30

Last Posted Date: 2012-07-25

Lead Sponsor: Pfizer

Target Recruit Count: 92

Registration Number: NCT00551148

Locations: 🇺🇸
Pfizer Investigational Site, Cincinnati, Ohio, United States

A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis

Phase 2

Completed

Conditions: Arthritis, Rheumatoid

Interventions: Drug: CP-690-550
Drug: CP-690,550
Drug: Placebo
Drug: Adalimumab

First Posted Date: 2007-10-29

Last Posted Date: 2013-01-03

Lead Sponsor: Pfizer

Target Recruit Count: 386

Registration Number: NCT00550446

Locations: 🇺🇦
Pfizer Investigational Site, Zaporizhzhia, Ukraine

Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets

Completed

Conditions: Diabetes Mellitus, Non-Insulin-Dependent
Hyperglycemia

First Posted Date: 2007-10-29

Last Posted Date: 2008-10-21

Lead Sponsor: Pfizer

Target Recruit Count: 32

Registration Number: NCT00550329

Locations: 🇸🇬
Pfizer Investigational Site, Singapore, Singapore

Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Phase 1

Completed

Conditions: Arthritis, Rheumatoid

Interventions: Drug: PD 0360324
Drug: Placebo

First Posted Date: 2007-10-29

Last Posted Date: 2009-07-14

Lead Sponsor: Pfizer

Target Recruit Count: 78

Registration Number: NCT00550355

Locations: 🇪🇸
Pfizer Investigational Site, Santiago de Compostela, A Coruña, Spain

A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.

Completed

Conditions: Neovascular Age-related Macular Degeneration

Interventions: Drug: Macugen

First Posted Date: 2007-10-25

Last Posted Date: 2018-12-06

Lead Sponsor: Pfizer

Target Recruit Count: 38

Registration Number: NCT00549055

Locations: 🇧🇪
Pfizer Investigational Site, Liege, Belgium

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy